Article
Opaganib Promotes Weight Loss and Suppresses High-Fat Diet-Induced Obesity and Glucose…
Diabetes, Metabolic Syndrome and Obesity · 2025 · Maines LW, Keller SN, Smith RA, Smith CD
Key facts
| Title | Opaganib Promotes Weight Loss and Suppresses High-Fat Diet-Induced Obesity and Glucose Intolerance |
|---|---|
| First author | Maines LW, Keller SN, Smith RA, Smith CD |
| Journal | Diabetes, Metabolic Syndrome and Obesity |
| Published | Apr 1, 2025 |
| DOI | 10.2147/DMSO.S514548 |
| Devices mentioned | 212378 |
At a glance
- 1–9 FDA submissions mentioned
- None Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1